// App-Quantinova.ai

e15095 : Tumor necrosis factor alpha, a neurotoxic proinflammatory cytokine for oxaliplatin-induced peripheral neuropathy.

Researchers

Presenter

  • Zohreh Ghoreishi

Principal Investigators

  • Ali Esfahani

  • Mohammad Asghari Jafarabadi

  • Hormoz Ayromlou

Medical Centers

  • Nutrition Research Center, Tabriz University of Medical Sciences, Tabriz, Iran, Tabriz, Iran

  • Nutrition Research Center, Tabriz University of Medical Sciences, Tabriz, Iran, Tabriz, Iran

  • Health Services Management Research Center and Department of Statistics and Epidemiology, Faculty of Health and Nutrition, Tabriz University of Medical Sciences, Tabriz, Iran

  • Nutrition Research Center, Tabriz University of Medical Sciences, Tabriz, Iran, Tabriz, Iran

Locations

  • Iran

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Peripheral neuropathy

  • Colorectal Cancer

  • Solid malignancies

Biomarkers

  • High sensitivity C-reactive protein

  • Interleukin 1

  • Interleukin 6

  • Tumor necrosis factor

Drug/Treatment

  • ILS-969

  • Oxaliplatin

  • Interleukin

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final